Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Kidney International Reports
|
October 27, 2025
Is Monotherapy Enough? Rethinking Strategies for Active Lupus Nephritis Network Meta-Analysis of Active Lupus Nephritis Treatment
Vittorio Di Maso, Giacomo Emmi
F1000 Medicine Reports
|
October 16, 2010
Is there an effective therapy available for non-alcoholic fatty liver disease?
Vittorio Di Maso, Stefano Bellentani
International Journal of Molecular Sciences
|
November 21, 2014
Small molecule membrane transporters in the mammalian podocyte: a pathogenic and therapeutic target
Cristina Zennaro, Mary Artero, Vittorio Di Maso, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
October 20, 2021
[Droghe d'abuso e rene]
Giuliano Boscutti, Vittorio Di Maso, Alessandra Marega, et al.
Journal of Chemotherapy (Florence, Italy)
|
August 21, 2023
Vancomycin-resistant enterococcus bloodstream infection successfully managed with oritavancin and fosfomycin as sequential treatment
Caterina Di Cecco, Jacopo Monticelli, Stefano Di Bella, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
June 29, 2024
[COVID-19 and Lupus Nephritis Flares in Unvaccinated Patients: A Case Report and Literature Review]
Brigitta Perencin, Alberto Zacchi, Fabrizio Zanconati, et al.
Pediatric Nephrology (Berlin, Germany)
|
July 26, 2023
Pioglitazone, a PPAR-y agonist, as one of the new therapeutic candidates for C3 glomerulopathy
Elia Balestra, Egidio Barbi, Viola Ceconi, et al.
Clinical Kidney Journal
|
April 11, 2015
Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile
Vittorio Di Maso, Michele Carraro, Elena Bevilacqua, et al.
Current Cardiology Reports
|
February 4, 2026
Cardiorenal and Metabolic Dimensions of Cardiomyopathies and Heart Failure: Focus on SGLT2i, GLP1-RA, and ns-MRA
Carla Indennidate, Brigitta Perencin, Vittorio Di Maso, et al.
The International Journal of Artificial Organs
|
January 25, 2022
Effects of the timing and intensity of treatment on septic shock patients treated with CytoSorb<sup>®</sup>: Clinical experience
Giorgio Berlot, Valentina Samola, Ilaria Barbaresco, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Kidney International Reports
|
October 27, 2025
Is Monotherapy Enough? Rethinking Strategies for Active Lupus Nephritis Network Meta-Analysis of Active Lupus Nephritis Treatment
Vittorio Di Maso, Giacomo Emmi
F1000 Medicine Reports
|
October 16, 2010
Is there an effective therapy available for non-alcoholic fatty liver disease?
Vittorio Di Maso, Stefano Bellentani
International Journal of Molecular Sciences
|
November 21, 2014
Small molecule membrane transporters in the mammalian podocyte: a pathogenic and therapeutic target
Cristina Zennaro, Mary Artero, Vittorio Di Maso, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
October 20, 2021
[Droghe d'abuso e rene]
Giuliano Boscutti, Vittorio Di Maso, Alessandra Marega, et al.
Journal of Chemotherapy (Florence, Italy)
|
August 21, 2023
Vancomycin-resistant enterococcus bloodstream infection successfully managed with oritavancin and fosfomycin as sequential treatment
Caterina Di Cecco, Jacopo Monticelli, Stefano Di Bella, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
June 29, 2024
[COVID-19 and Lupus Nephritis Flares in Unvaccinated Patients: A Case Report and Literature Review]
Brigitta Perencin, Alberto Zacchi, Fabrizio Zanconati, et al.
Pediatric Nephrology (Berlin, Germany)
|
July 26, 2023
Pioglitazone, a PPAR-y agonist, as one of the new therapeutic candidates for C3 glomerulopathy
Elia Balestra, Egidio Barbi, Viola Ceconi, et al.
Clinical Kidney Journal
|
April 11, 2015
Warfarin-related nephropathy: possible role for the warfarin pharmacogenetic profile
Vittorio Di Maso, Michele Carraro, Elena Bevilacqua, et al.
Current Cardiology Reports
|
February 4, 2026
Cardiorenal and Metabolic Dimensions of Cardiomyopathies and Heart Failure: Focus on SGLT2i, GLP1-RA, and ns-MRA
Carla Indennidate, Brigitta Perencin, Vittorio Di Maso, et al.
The International Journal of Artificial Organs
|
January 25, 2022
Effects of the timing and intensity of treatment on septic shock patients treated with CytoSorb<sup>®</sup>: Clinical experience
Giorgio Berlot, Valentina Samola, Ilaria Barbaresco, et al.
Page
of 3